Molecular diagnostics, Loop-Mediated Isothermal Amplification (LAMP) has emerged as a powerful tool, offering rapid and accurate detection of target DNA and RNA with minimal equipment requirements. This technique holds particular promise for Point-of-Care Testing (POCT), facilitating timely diagnoses in various clinical settings.

LAMP Applications

Introduction to Products Facilitating LAMP-Based Molecular POCT

Bst DNA Polymerase V2 by Hzymes Biotech:
Hzymes Biotech introduces Bst DNA Polymerase V2, a cutting-edge enzyme tailored for LAMP applications. This polymerase boasts remarkable attributes including:

• Fast Amplification Speed: Accelerating the diagnostic process, Bst DNA Polymerase V2 ensures swift amplification of target nucleic acids.
• Strong Resistance to PCR Inhibitors: Overcoming common inhibitors present in clinical samples, this polymerase ensures reliable results even in challenging conditions.
• Good Sample Compatibility: Compatible with diverse sample types, Bst DNA Polymerase V2 facilitates seamless integration into various diagnostic workflows.

RTL Reverse Transcriptase 2.0:

RTL Reverse Transcriptase 2.0 represents a breakthrough in reverse transcription technology, offering unparalleled efficiency and stability essential for RT-LAMP reagent development. Key features include:

• High Reverse Transcription Efficiency: Enabling accurate conversion of RNA into complementary DNA (cDNA), RTL Reverse Transcriptase 2.0 ensures sensitive detection of RNA targets.
• Robust Freeze-Thaw Stability: Withstanding fluctuations in temperature, this enzyme maintains its activity across multiple freeze-thaw cycles, ensuring long-term reliability.
• Strong Inhibitor Tolerance: Resilient to inhibitory substances commonly encountered in clinical samples, RTL Reverse Transcriptase 2.0 guarantees consistent performance in challenging environments.


Comprehensive LAMP One-Stop Solution

In response to the growing demand for streamlined molecular POCT solutions, Hzymes Biotech offers a comprehensive LAMP one-stop solution. This integrated package includes:

• High-performance Bst DNA Polymerase V2 for rapid target amplification.
• RTL Reverse Transcriptase 2.0 for efficient conversion of RNA into cDNA, facilitating RT-LAMP assay development.
• Customizable reagent formulations tailored to specific diagnostic needs, ensuring optimal performance and reliability.


Conclusion

Hzymes Biotech’s Bst DNA Polymerase V2 and RTL Reverse Transcriptase 2.0 represent cutting-edge solutions for LAMP-based molecular POCT. By combining fast amplification speed, robust inhibitor tolerance, and high reverse transcription efficiency, these products empower clinicians and researchers to perform rapid and accurate diagnostics in resource-limited settings. With our comprehensive LAMP one-stop solution, we aim to accelerate the adoption of molecular POCT, ultimately improving patient outcomes and advancing healthcare delivery worldwide.

In the future, Hzymes biotech will always remember its original intention and persist in meticulous cultivation in the IVD field. It will adhere to independent research and development, accelerate the construction of a world-class specialty enzyme production platform, and achieve import substitution of core enzyme raw materials in the field of biomedicine in China. It will collaborate with leading biopharmaceutical companies to expand their global presence and contribute to the advancement of the industry.